Trends of presentation and clinical outcome of treated renal angiomyolipoma
- PMID: 20635448
- PMCID: PMC2908871
- DOI: 10.3349/ymj.2010.51.5.728
Trends of presentation and clinical outcome of treated renal angiomyolipoma
Abstract
Purpose: The purpose of this study is to set guidelines for the management of renal angiomyolipoma (AML), clinical prognosis according to tumor size, in association with tuberous sclerosis complex (TSC), multiplicity, radiographic finding, and treatment modality.
Materials and methods: Between March 1998 and October 2008, 129 out of 254 patients with AML who underwent surgical intervention or angioembolization were enrolled. Diagnosis of AML was determined by the presence of a low attenuated component on CT imaging or by pathological confirmation. Indications of treatment were intractable pain, hematuria, suspicion of malignancy, large tumor size, spontaneous rupture, and radiographically equivocal tumors in which a differential diagnosis was needed to rule out malignancy. Parameters including age, sex, tumor size, multiplicity, radiographic characteristics, association with TSC, and treatment modality were reviewed.
Results: Age at presentation was 50.6 years and mean tumor size was 3.5 cm. Presentation symptoms were flank pain, hematuria, spontaneous rupture, and fatigue. 97 (75.2%) patients were incidentally discovered. 100 (77.5%) were females. 68 (52.7%) underwent nephron-sparing surgery (NSS), 35 (27.1%) radical nephrectomy, and 26 (20.2%) angioembolization. TSC was accompanied in 12 (9.3%) patients. No patient developed renal function impairment during the mean follow-up period of 64.8 months. Patients with TSC presented at a younger age, along with larger, bilateral, and multiple lesions.
Conclusion: Significant differences in clinical manifestations and treatment outcomes were noted in respect to tumor characteristics, association with TSC, and treatment modality. Considering the benign nature of AML, these parameters ought to be considered when deciding upon active surveillance or prophylactic intervention.
Conflict of interest statement
The authors have no financial conflicts of interest.
Similar articles
-
Changing trends in presentation, diagnosis and management of renal angiomyolipoma: comparison of sporadic and tuberous sclerosis complex-associated forms.Urology. 2008 Nov;72(5):1077-82. doi: 10.1016/j.urology.2008.07.049. Epub 2008 Sep 21. Urology. 2008. PMID: 18805573
-
[Nephron sparing surgery as a treatment modality for renal angiomyolipoma].Harefuah. 2005 Sep;144(9):619-21, 678, 677. Harefuah. 2005. PMID: 16218531 Hebrew.
-
Active surveillance for renal angiomyolipoma: outcomes and factors predictive of delayed intervention.BJU Int. 2014 Sep;114(3):412-7. doi: 10.1111/bju.12604. Epub 2014 Apr 16. BJU Int. 2014. PMID: 24325283
-
Renal angiomyolipoma with tuberous sclerosis complex: How it differs from sporadic angiomyolipoma in both management and care.Asian J Surg. 2020 Oct;43(10):967-972. doi: 10.1016/j.asjsur.2019.12.008. Epub 2020 Jan 17. Asian J Surg. 2020. PMID: 31959574 Review.
-
[Extrarenal angiomyolipoma with spontaneous rupture: a case report].Hinyokika Kiyo. 2008 Jul;54(7):485-8. Hinyokika Kiyo. 2008. PMID: 18697493 Review. Japanese.
Cited by
-
Clinical practice recommendations for kidney involvement in tuberous sclerosis complex: a consensus statement by the ERKNet Working Group for Autosomal Dominant Structural Kidney Disorders and the ERA Genes & Kidney Working Group.Nat Rev Nephrol. 2024 Jun;20(6):402-420. doi: 10.1038/s41581-024-00818-0. Epub 2024 Mar 5. Nat Rev Nephrol. 2024. PMID: 38443710 Review.
-
Angiomyolipoma of the kidney-Clinicopathological analysis of 52 cases.Pathol Oncol Res. 2023 Jan 9;28:1610831. doi: 10.3389/pore.2022.1610831. eCollection 2022. Pathol Oncol Res. 2023. PMID: 36699622 Free PMC article.
-
Safety and Effectiveness of Medical Therapy and Surgical Intervention for Renal Angiomyolipoma Associated With Tuberous Sclerosis Complex.Cancer Control. 2022 Jan-Dec;29:10732748221140266. doi: 10.1177/10732748221140266. Cancer Control. 2022. PMID: 36471546 Free PMC article.
-
Cystic epitholiod angiomyolipoma mimicking a cystic renal cell carcinoma: A case report.Urol Case Rep. 2022 Aug 5;45:102186. doi: 10.1016/j.eucr.2022.102186. eCollection 2022 Nov. Urol Case Rep. 2022. PMID: 35991215 Free PMC article.
-
Spectrum of Presentations and Management Strategies in Renal Angiomyolipoma.J Kidney Cancer VHL. 2022 Jan 28;9(1):42-47. doi: 10.15586/jkcvhl.v9i1.221. eCollection 2022. J Kidney Cancer VHL. 2022. PMID: 35127338 Free PMC article.
References
-
- Hadley DA, Bryant LJ, Ruckle HC. Conservative treatment of renal angiomyolipomas in patients with tuberous sclerosis. Clin Nephrol. 2006;65:22–27. - PubMed
-
- Bae SK, Lee SW, Jung S, Song KS, Kim GA, Jeon JB, et al. A case of bilateral renal angiomyolipoma associated with tuberous sclerosis. Korean J Nephrol. 1997;16:793–796.
-
- Kim JW, Lee TW, Kim MJ, Oh MM, Bae JH, Park HS, et al. Spontaneous rupture of renal angiomyolipoma in a female tuberous sclerosis patient with pulmonary lymphangioleiomyomatosis. Korean J Urol. 2007;48:344–347.
-
- Danforth TL, Lane BR, Novick AC. Conservative management of giant symptomatic angiomyolipomas in patients with the tuberous sclerosis complex. BJU Int. 2007;100:794–797. - PubMed
-
- Ha HK, Seo HK, Chung MK. Radiologic characteristics of renal angiomyolipoma with minimal fat. Korean J Urol. 2004;45:163–167.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical